These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7422098)

  • 1. Central and peripheral dopamine beta hydroxylase: responses to long term treatment with monoamine oxidase inhibitors.
    Lerner P; Major LF; Dendel PS; Campbell IC; Murphy DL
    Neuropharmacology; 1980 Sep; 19(9):877-81. PubMed ID: 7422098
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neuroleptics, monoamine oxidase inhibitors and dopamine beta hydroxylase inhibitors: their actions and interactions].
    Vetulani J
    Postepy Hig Med Dosw; 1973; 27(6):725-80. PubMed ID: 4589208
    [No Abstract]   [Full Text] [Related]  

  • 3. Aggression and central neurotransmitters.
    Pradhan SN
    Int Rev Neurobiol; 1975; 18():213-62. PubMed ID: 1353
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the effect of various digitalis substances on monoamine oxidase activity in rat, guinea pig and cat brain].
    Popov N; Förster W
    Acta Biol Med Ger; 1966; 17(2):221-31. PubMed ID: 5983237
    [No Abstract]   [Full Text] [Related]  

  • 5. Catecholamines.
    Axelrod J; Weinshilboum R
    N Engl J Med; 1972 Aug; 287(5):237-42. PubMed ID: 4402575
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
    Green AR; Mitchell BD; Tordoff AF; Youdim MB
    Br J Pharmacol; 1977 Jul; 60(3):343-9. PubMed ID: 890205
    [No Abstract]   [Full Text] [Related]  

  • 7. Rat brain monoamine oxidase inhibition by beta-diethylaminoethyl diphenylprophylacetate (SKF-525A).
    Pfeffer M; Semmel M; Schor JM
    Enzymologia; 1968 Jul; 34(5):299-303. PubMed ID: 5672567
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification of brain mitochondrial monoamine oxidase activities by hydroxyethylhydrazide of cyanoacetic acid and some other monoamine oxidase inhibitors.
    Baumanis EA; Kalnina IE; Moskvitina TA; Gorkin VZ
    Biochem Pharmacol; 1977 Jun; 26(11):1059-63. PubMed ID: 18152
    [No Abstract]   [Full Text] [Related]  

  • 9. Distribution and inhibition characteristics of human brain monoamine oxidase.
    Owen F; Cross AJ; Lofthouse R; Glover V
    Biochem Pharmacol; 1979 Apr; 28(7):1077-80. PubMed ID: 444264
    [No Abstract]   [Full Text] [Related]  

  • 10. Deamination of dopamine and its 3-O-methylated derivative by human brain monoamine oxidase.
    Roth JA; Feor K
    Biochem Pharmacol; 1978; 27(11):1606-8. PubMed ID: 697902
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro inhibition of brain mitochondrial monoamine oxidase by 6-hydroxydopamine.
    Youdim MB
    Br J Pharmacol; 1975 Jul; 54(3):403-5. PubMed ID: 1164597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mice on tyrosine hydroxylase, L-3,4-dihydroxyphenylalanine decarboxylase, dopamine beta-hydroxylase, and monoamine oxidase activities in the striatum and hypothalamus.
    Mogi M; Harada M; Kojima K; Kiuchi K; Nagatsu T
    J Neurochem; 1988 Apr; 50(4):1053-6. PubMed ID: 2894407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone.
    Fowler CJ; Benedetti MS
    J Neurochem; 1983 Jun; 40(6):1534-41. PubMed ID: 6406646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of rodent brain monoamine oxidase and tyrosine hydroxylase by endogenous compounds - 1,2,3,4-tetrahydro-isoquinoline alkaloids.
    Patsenka A; Antkiewicz-Michaluk L
    Pol J Pharmacol; 2004; 56(6):727-34. PubMed ID: 15662085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for inhibition of dopamine-beta-hydroxylase in vivo after sub-acute pyrazole treatment in rats.
    MacDonald E; Pispa JP
    Med Biol; 1977 Oct; 55(5):284-91. PubMed ID: 22792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs.
    Neff NH; Yang HY
    Life Sci; 1974 Jun; 14(11):2061-74. PubMed ID: 4603266
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of age on the recovery of cardiac monoamine oxidase after irreversible inhibition.
    Horita A
    Biochem Pharmacol; 1968 Oct; 17(10):2091-6. PubMed ID: 5696878
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine-beta-hydroxylase and norepinephrine in human cerebrospinal fluid: effects of monoamine oxidase inhibitors.
    Lerner P; Major LF; Murphy DL; Lipper S; Lake CR; Lovenberg W
    Neuropharmacology; 1979 Apr; 18(4):423-6. PubMed ID: 450208
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of acetylcholine on monoamine oxidase.
    Mohammed YS; Osman MY; Mahfouz MM
    Biochem Pharmacol; 1976 Jul; 25(14):1665-7. PubMed ID: 942467
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biochemistry of depression and antidepressants].
    Strolin Benedetti M
    Encephale; 1982; 8(5):545-85. PubMed ID: 6189704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.